These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 8150554

  • 1. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
    Collinson AR, Lambert JM, Liu Y, O'Dea C, Shah SA, Rasmussen RA, Goldmacher VS.
    Int J Immunopharmacol; 1994 Jan; 16(1):37-49. PubMed ID: 8150554
    [Abstract] [Full Text] [Related]

  • 2. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
    Rasmussen RA, Counts SL, Lambert JM, Collinson AR.
    Cancer Immunol Immunother; 1992 Jan; 35(5):355-63. PubMed ID: 1394340
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL, Li JL, Vitetta ES.
    J Immunol; 1994 Mar 01; 152(5):2368-76. PubMed ID: 8133047
    [Abstract] [Full Text] [Related]

  • 8. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA, Halloran PM, Ferris CA, Levine BA, Bourret LA, Goldmacher VS, Blättler WA.
    Cancer Res; 1993 Mar 15; 53(6):1360-7. PubMed ID: 7680284
    [Abstract] [Full Text] [Related]

  • 9. [Preparation and study of cytotoxic properties of the immunotoxin anti-CD7/A-chain of ricin].
    Tonevitskiĭ AG, Ershova GV, Agapov II, Toptygin AIu, Korotkova OV, Shereshkov SN, Kadagidze ZG, Baryshnikov AIu.
    Dokl Akad Nauk SSSR; 1991 Mar 15; 317(3):749-53. PubMed ID: 1720085
    [No Abstract] [Full Text] [Related]

  • 10. Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
    Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blättler WA.
    Blood; 1992 Feb 01; 79(3):576-85. PubMed ID: 1370636
    [Abstract] [Full Text] [Related]

  • 11. Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26.
    Duke-Cohan JS, Morimoto C, Schlossman SF.
    Blood; 1993 Oct 01; 82(7):2224-34. PubMed ID: 8104537
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
    Fishwild DM, Aberle S, Bernhard SL, Kung AH.
    Cancer Res; 1992 Jun 01; 52(11):3056-62. PubMed ID: 1375534
    [Abstract] [Full Text] [Related]

  • 14. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
    Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Blättler WA.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6236-42. PubMed ID: 1718599
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM.
    Transplantation; 1987 Mar 01; 43(3):421-6. PubMed ID: 3103275
    [Abstract] [Full Text] [Related]

  • 17. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
    Tazzari PL, Bolognesi A, De Totero D, Lemoli RM, Fortuna A, Conte R, Crumpton MJ, Stirpe F.
    Br J Haematol; 1994 Jan 01; 86(1):97-105. PubMed ID: 7912101
    [Abstract] [Full Text] [Related]

  • 18. Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
    Epstein C, Lynch T, Shefner J, Wen P, Maxted D, Braman V, Ariniello P, Coral F, Ritz J.
    Int J Cancer Suppl; 1994 Jan 01; 8():57-9. PubMed ID: 7515030
    [Abstract] [Full Text] [Related]

  • 19. Induction and increase of HLA-DR antigen expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity.
    Chiron M, Jaffrezou JP, Carayon P, Bordier C, Roubinet F, Xavier C, Brandely M, Laurent G.
    Clin Exp Immunol; 1990 Nov 01; 82(2):214-20. PubMed ID: 2122930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.